324 related articles for article (PubMed ID: 23953023)
1. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.
Herzallah MM; Moustafa AA; Natsheh JY; Danoun OA; Simon JR; Tayem YI; Sehwail MA; Amleh I; Bannoura I; Petrides G; Myers CE; Gluck MA
J Affect Disord; 2013 Nov; 151(2):484-492. PubMed ID: 23953023
[TBL] [Abstract][Full Text] [Related]
2. Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants.
Herzallah MM; Moustafa AA; Natsheh JY; Abdellatif SM; Taha MB; Tayem YI; Sehwail MA; Amleh I; Petrides G; Myers CE; Gluck MA
Front Integr Neurosci; 2013; 7():67. PubMed ID: 24065894
[TBL] [Abstract][Full Text] [Related]
3. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
4. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
5. Personality change during depression treatment: a placebo-controlled trial.
Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
[TBL] [Abstract][Full Text] [Related]
6. Peripheral microvascular serotoninergic signaling is dysregulated in young adults with major depressive disorder.
Greaney JL; Dillon GA; Saunders EFH; Alexander LM
J Appl Physiol (1985); 2020 Jan; 128(1):100-107. PubMed ID: 31751182
[TBL] [Abstract][Full Text] [Related]
7. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
8. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
9. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective serotonin reuptake inhibitor on prefrontal-striatal connectivity is dependent on the level of TNF-α in patients with major depressive disorder.
Liu K; Zhao X; Lu X; Zhu X; Chen H; Wang M; Yan W; Jing L; Deng Y; Yu L; Wu H; Wen G; Sun X; Lv Z
Psychol Med; 2019 Nov; 49(15):2608-2616. PubMed ID: 30520409
[TBL] [Abstract][Full Text] [Related]
11. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
12. Different functioning of prefrontal cortex predicts treatment response after a selective serotonin reuptake inhibitor treatment in patients with major depression.
Masuda K; Nakanishi M; Okamoto K; Kawashima C; Oshita H; Inoue A; Takita F; Izumi T; Ishitobi Y; Higuma H; Kanehisa M; Ninomiya T; Tanaka Y; Akiyoshi J
J Affect Disord; 2017 May; 214():44-52. PubMed ID: 28266320
[TBL] [Abstract][Full Text] [Related]
13. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
[TBL] [Abstract][Full Text] [Related]
14. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine in the treatment of adolescent major depression.
Correll CU; Pleak RR
J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1269; author reply 1270. PubMed ID: 12410065
[No Abstract] [Full Text] [Related]
16. Paroxetine in the treatment of adolescent major depression.
Silveira R; Jainer AK; Singh R
J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1270; author reply 1271. PubMed ID: 12410066
[No Abstract] [Full Text] [Related]
17. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
Landén M; Högberg P; Thase ME
J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants.
Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H
Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252
[TBL] [Abstract][Full Text] [Related]
19. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
Kertzman S; Vainder M; Reznik I; Gotzlav Y; Weizman A; Kotler M; Iancu I
Int Clin Psychopharmacol; 2012 May; 27(3):134-41. PubMed ID: 22415223
[TBL] [Abstract][Full Text] [Related]
20. The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Sugawara N; Kaneko S
PLoS One; 2014; 9(5):e98099. PubMed ID: 24858363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
